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Early stage non–small-cell lung cancer treatment relies on radical surgery, which radically improves the progno-
sis. However, pulmonary resections lead to complications. 
Prolonged air leaks are one of the most frequent.1 By the 
way, different techniques have been developed to prevent 
prolonged air leaks: fibrin glue, synthetic polymers, and 
bovine pericardium. FOREseal bioabsorbable sleeve for 
lung staple-line reinforcement is now widely used, following 
the results of a phase II multicentric study.2
Follow-up of operated early stages non–small-cell 
lung cancer patients is usually based on computed tomog-
raphy (CT) scan images that might sometimes surpris-
ingly evolve after surgery with a sleeve for staple-line 
reinforcement.
For example is a 72-year-old man followed in our 
department after left lower lobectomy associated with 
lymphadenectomy for a pT2aN1M0 squamous cell carci-
noma. The follow-up CT performed after adjuvant carbo-
platin and paclitaxel based chemotherapy was negative. 
However, 4 years after diagnosis, a left infrahilar lesion 
appeared close to the resected area (Fig. 1). A positron emis-
sion tomography CT was performed, showing a hyperme-
tabolism of this lesion (SUV 3.5 g/ml) (Fig. 2). Fibroscopy 
and cytology were negative. Transparietal CT guided biop-
sies were performed. Pathology showed collagenic tissue 
without tumor cells. This patient is still alive and disease 
free 6 years after diagnosis.
We already know that air leaks after thoracic surgery 
have a major impact on the morbidity, duration of hospi-
talization, and costs and that the use of sealant for pneu-
monectomies or lobectomies is efficient to avoid suture 
dehiscence. Therefore, prophylactic techniques for prevent-
ing prolonged air leaks are widely used in thoracic surgery. 
The use of staple-line reinforcement significantly decreases 
the leak volume (38.5 versus 59.9 ml, p = 0.041) and the 
duration of hospitalization (33 versus 63 hours, p = 0.013) 
after lobectomy.3
Few similar examples of tumor relapse suspicion 
have been published either with the same reinforcement 
sleeve2 or with other sleeves such as bovine pericardium4 or 
synthetic sealant.5 Furthermore, these pseudo-tumors may 
occur early and several years after surgery with staple-line 
reinforcement. This case points a potential cause of mis-
take for clinicians. Staple-line reinforcement may mimic 
tumor relapse. Therefore, oncologists must be aware of 
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FIGURE 1.  Computed tomography scan showed a left infra-
hilar opacity next to the surgical site.
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the existence of sealant complications mimicking cancer 
relapse. A multidisciplinary team discussion together with 
a pathological examination is obviously always required to 
exclude a tumor relapse. However, knowing this rare out-
come may speed up the work up and reinsure patients and 
physicians when following-up with lung cancer patients 
treated with a bronchial reinforcement after thoracic sur-
gery. This may also avoid morbidity and over costs of 
unuseful exams or surgery.
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FIGURE 2.  Positron emission tomography computed 
tomography showed a hypermetabolism of the left hilar 
opacity (SUV 3 g/ml).
